Listerine with fluoride meeting postponed
This article was originally published in The Rose Sheet
Executive Summary
"Feedback" meeting on OTC anticaries drug products monograph slated for June 18 in Rockville, MD will be rescheduled, probably within a month, according to FDA's division of OTC Drug Products. Meeting is part of Pfizer's efforts to amend the monograph to allow a mouthrinse combining essential oils and sodium fluoride (1'The Rose Sheet" June 10, 2002, p. 5). FDA says it needs more time to review relevant materials...
You may also be interested in...
Listerine With Fluoride Development Continues With “Feedback” Meeting
Pfizer Consumer Healthcare plans to conduct a six-month clinical study involving at least 300 subjects to determine whether adding .02% sodium fluoride to the company's Listerine mouthrinse affects the antiplaque/ antigingivitis effectiveness of the product
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.